-
Products
-
Science
-
Blog
-
About
We use cookies and similar technologies to provide the best experience on our website.
Our Impact
We believe women deserve better healthcare—full stop.
So, we're committing 10% of our net profit to causes working to close the health gap between women and men. From research to patient care and health outcomes, here's where women are still being left behind.
Closing the women's health gap could add $1 trillion to the global economy each year by 2040.
The average delay in getting an endometriosis diagnosis across studies included in a research review.
Heart disease caused about one in five deaths among U.S. women in 2023.
This isn't a feeling.
It's the record.
Across research, funding, dosing, and training, the system was built around men. Here's some of what that looks like.
-
1977 to 1993
The years the FDA kept most women of childbearing age out of early drug trials, before the law finally required them in federally funded research.
-
2016
The year the NIH finally required female animals and cells in funded research. For decades before, basic lab science ran on male mice, male rats, and male cells.
-
38%
of the participants across 740 heart-disease trials from 2010 to 2017 were women.
-
$1.2B vs $44M
What men's health and erectile-dysfunction startups raised from 2019 to 2023, next to endometriosis funding. Endometriosis affects about 1 in 10 women.
-
About 1%
of health research funding from 2019 to 2023 went to the conditions that drive most of the women's health gap.
-
Nearly 75%
of the diseases that mainly affect one sex are funded by the NIH in favor of men, not women.
-
2x
as often as men, women have adverse drug reactions, because standard doses were built around male bodies.
Source: Zucker & Prendergast, Biology of Sex Differences, 2020
-
86 drugs
that women clear more slowly than men, flagged in a 2020 review, enough to risk an overdose at a standard dose.
Source: Zucker & Prendergast, Biology of Sex Differences, 2020
-
8 of 10
drugs pulled from the market for safety, in one GAO audit, were more dangerous to women than to men.
-
About 4%
of FDA drug labels include sex-specific dosing, even where men and women process the drug differently.
Source: Stanford Gendered Innovations
-
About 70%
of medical schools, in one survey, reported no formal sex- and gender-based medicine in the curriculum.
-
1 in 5
OB-GYN residents report a formal menopause curriculum in their training. Only that many.
-
50% more likely
than men to be misdiagnosed after a heart attack, simply for being a woman.
Source: University of Leeds / British Heart Foundation, 2016
Women's health deserves more.
We're committing 10% of Seya's net profit to causes working to close the health gap. More research that includes women. Better care. Better health outcomes.
